-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD) patients usually refer to Crohn's disease (CD) and ulcerative colitis (UC) patients.
Patients with these two diseases are at a significantly increased risk of infection
.
In IBD patients, the risk of infectious diseases such as soft tissue infections, urological infections, gynecological infections, and pneumonia has been significantly increased
Inflammatory bowel disease (IBD) patients usually refer to Crohn's disease (CD) and ulcerative colitis (UC) patients.
This study is a retrospective cohort and nested case-control study
.
The researchers matched patients with IBD and patients without IBD in terms of age, gender, enrollment, and region
diagnosis
The study finally identified 50029 Crohn's disease (CD) patients and 59830 ulcerative colitis (UC) patients who were matched with 296801 non-IBD controls
.
There were 85 CD patients, 77 UC patients, and 235 controls with meningitis
Figure: Analysis of risk factors for meningitis
This study confirms that although the overall incidence of meningitis is lower, compared with non-IBD controls, patients with IBD have an increased risk
.
Complications are a risk factor for meningitis in patients with IBD
This study confirms that although the overall incidence of meningitis is lower, compared with non-IBD controls, patients with IBD have an increased risk
Original source:
Kochar.
Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis.
Leave a message here
